Skip to main content
. 2018 Nov 5;10:715–721. doi: 10.2147/CEOR.S177338

Table 4.

Incremental cost-effectiveness ratios for severe bleeding events avoided

Endpoint ICER
EPAG/ROMI EPAG/W&R
Incremental cost per responder Dominant US$62,749
Incremental cost per severe bleeding event avoided (WHO 3–5) Dominant US$354,197
Incremental cost per bleeding event avoided (WHO 2–5) Dominant US$189,303
Incremental cost per patient Dominant US$62,749

Note: All costs are listed in USD.

Abbreviations: ICER, incremental cost-effectiveness ratio; EPAG, eltrombopag; ROMI, romiplostim; W&R, watch-and-rescue.